5 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 5 of 5 clinical reviews.
A clinician-focused guide to denosumab dosing, pharmacogenomics, and efficacy data in East Asian patients, including ethnicity-stratified subgroup results, BMI thresholds, and hypocalcemia risk.
Evidence-based guide to denosumab (Prolia) dosing in Hispanic and Latino patients, covering pharmacogenomics, bone density data, clinical trial subgroups, and monitoring recommendations.
A clinically detailed review of denosumab safety, pharmacogenomics, and dosing considerations specific to Hispanic and Latino patients, with ethnicity-stratified trial data, guideline citations, and practical prescribing guidance.
Evidence-based review of how denosumab (Prolia) performs in Black and African ancestry patients, including FREEDOM trial subgroup data, pharmacogenomic factors, and dosing considerations.
Evidence-based review of how denosumab (Prolia) safety, metabolism, and fracture outcomes may differ in South Asian populations, including pharmacogenomic considerations and clinical monitoring guidance.